[1] Hopkins AL. Network pharmacology:the next paradigm in drug discovery[J]. Nat Chem Biol,2008,4(11), 682-690.
[2] Fang J, Wang L, Wu T,et al. Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment[J]. J Ethnopharmacol,2017,196:281-292.
[3] 李梢.网络靶标:中药方剂网络药理学研究的一个切入点[J].中国中药杂志,2011,36(15):2017-2020.
[4] Yang M, Chen JL, Xu LW, et al. Navigating traditional chinese medicine network pharmacology and computational tools[J]. Evidence-based Complement Altern Med,2013, 2013:731969.
[5] 薛潇春,胡晋红.网络药理学的研究方法与应用进展[J].药学实践杂志,2015,33(5):401-405.
[6] 周文霞,王同兴,程肖蕊,等. 网络药理学研究中的网络构建技术[J].国际药学研究杂志,2016,43(5):791-812.
[7] 何艳,于云莉,杨帆.基于复杂网络可视化的癫痫患者大脑状态研究[J]. 中国医疗设备,2016,31(9):39-42.
[8] Lecca P, Re A. Network-oriented approaches to anticancer drug response[J]. Cancer Gene Networks,2016,03:101-117.
[9] 周文霞,王同兴,程肖蕊,等.网络药理学研究中的网络分析技术[J].国际药学研究杂志,2016,43(3):399-409.
[10] Li B,Xu X,Wang X, et al. A systems biology approach to understanding the mechanisms of action of Chinese herbs for treatment of cardiovascular disease[J]. Int J Molecul Sci,2012,13(10):13501-13520.
[11] Tao W, Xu X, Wang X, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease[J].J Ethnopharmacol,2013, 145(1):1-10.
[12] Li X, Wu L, Liu W, et al.A networkpharmacology study of Chinese medicine QiShenYiQi to reveal its underlying multi-compound, multi-target, multi-pathway mode of action[J]. PloS ONE,2014, 9(5):e95004.
[13] Fang HY, Zeng HW, Lin LM, et al. A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases[J]. Sci Rep, 2017,7:43632.
[14] Hong M, Wang N,Feng Y,et al. A Biomedical investigation of the hepatoprotective effect of Radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets[J]. Int J Molecul Sci,2017,18(3):620.
[15] An L, Feng F.Network pharmacology-based antioxidant effect study of zhi-zi-da-huang decoction for alcoholic liver disease[J]. Evidence-based Complement Altern Med,2015,2015:492470.
[16] Zhang B, Lu C, Bai M,et al.Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury[J]. J Ethnopharmacol,2015,175:638-647.
[17] Wei S, Niu M, Wang J, et al.A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis[J]. Drug Design Development and Therapy,2016, 10:733-743.
[18] van Berlo D,Hullmann M,Schins RP.Toxicology of ambient particulate matter[J]. Molecul, Clini Environment Toxicol,2012,101:165-217.
[19] Yu G, Zhang Y, Ren W, et al.Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis[J]. In J Chron Obstruct Pulmon Dis,2017, 12:85-94.
[20] Hou Y, Nie Y, Cheng B,et al.Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways[J]. Acta Pharmaceutica Sinica B,2016,6(3):212-221.
[21] Tao J, Hou Y, Ma X,et al. An integrated global chemomics and system biology approach to analyze the mechanisms of the traditional Chinese medicinal preparation Eriobotrya japonica-Fritillaria usuriensis dropping pills for pulmonary diseases[J]. BMC Complement Altern Med,2016,16:4.
[22] Xiang Z, Sun H, Cai X,et al. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology[J]. Molecular Biosystems, 2015,11(4):1067-1078.
[23] Shi SH, Cai YP, Cai XJ, et al. A network pharmacology approach to understanding the mechanisms of action of traditional medicine:Bushenhuoxue formula for treatment of chronic kidney disease[J]. PloS ONE,2014,9(3):e89123.
[24] Wang J,Yao K,Yang X,et al.Chinese patent medicineliu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension:a systematic review of randomized controlled trials[J]. Evidence-based Complement Altern Med, 2012, 2012:714805.
[25] Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae:the Liu-Wei-Di-Huang pill as a case study[J]. Molecular Biosystems,2014,10(5):1014-1022.
[26] Wang HH,Zhang BX,Ye XT, et al. Study on mechanism for anti-depression efficacy of Sini San through auxiliary mechanism elucidation system for Chinese medicine[J]. Zhongguo Zhong Yao Za Zhi,2015,40(19):3723-3728.
[27] Margineanu DG. Systems biology, complexity, and the impact on antiepileptic drug discovery[J]. Epilepsy Behav,2014,38:131-142.
[28] Guo Q, Mao X, Zhang Y,et al. Guizhi-Shaoyao-Zhimu decoction attenuates rheumatoid arthritis partially by reversing inflammation-immune system imbalance[J]. J Transl Med, 2016,14(1):165.
[29] Zhang Y, Wang D, Tan S, et al. A systems biology-based investigation into the pharmacological mechanisms of wu tou tang acting on rheumatoid arthritis by integrating network analysis[J]. Evidence-based Complement Altern Med,2013,2013:548498.
[30] Zhang Y, Mao X, Guo Q, et al. Pathway of PPAR-gamma coactivators in thermogenesis:a pivotal traditional Chinese medicine-associated target for individualized treatment of rheumatoid arthritis[J]. Oncotarget,2016,7(13):15885-15900.
[31] Chen Y, Palczewski K. Systems pharmacology links GPCRs with retinal degenerative disorders[J]. Ann Rev Pharmacol Toxicol,2016,56:273-298.
[32] Liu H, Zeng L, Yang K. A network pharmacology approach to explore the pharmacological mechanism of Xiaoyao powder on anovulatory infertility[J]. Evidence-based Complement Altern Med,2016,2016:1-13.
[33] Tang F, Tang Q, Tian Y,et al. Network pharmacology-based prediction of the active ingredients and potential targets of Mahuang Fuzi Xixin decoction for application to allergic rhinitis[J]. J Ethnopharmacol,2015,176:402-412.